IPSEY:OTCMKTS
Ipsen ADR Rep 1/4 Ord Shs
US$ ४०.१५
arrow_upward
+०.६५%(+०.२६) 1D
अक्टोबर ८, १६:००:०० GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IPSEY...
Open
US$ ३९.१२
High
US$ ४०.१५
Low
US$ ३९.१२
Mkt. cap
१२.१२ अरब
Avg. vol.
८४२.००
Volume
१६.३४ हजार
52-wk high
US$ ५१.१०
52-wk low
US$ ३२.६८
Beta
०.४१
Shares outstanding
३३.५३ करोड
No. of employees
६ हजार
Open
US$ ३९.१२
High
US$ ४०.१५
Low
US$ ३९.१२
Mkt. cap
१२.१२ अरब
Avg. vol.
८४२.००
Volume
१६.३४ हजार
52-wk high
US$ ५१.१०
52-wk low
US$ ३२.६८
Beta
०.४१
Shares outstanding
३३.५३ करोड
No. of employees
६ हजार
News stories
From web sources and news partners
Ideal Investisseur
·
१२ घण्टा पहिले
Weighed Down by 13% in One Month, Ipsen Stock Declines Further Following Jefferies Downgrade
TipRanks
·
१ दिन पहिले
Ipsen Reports September 2026 Share Capital and Voting Rights
Stock Titan
·
१ दिन पहिले
Some Ipsen shares count twice: 83.8 million shares came with 132 million votes.
Profile
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees worldwide. Ipsen's medicines are registered in 88 countries with direct commercial presence in over 30 countries. Ipsen has 4 global R&D hubs and 3 pharmaceutical development centers around the world. Ipsen has been a family-owned business for the past 90 years and is publicly traded on the Euronext Paris as part of the SBF 120 index. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Wikipedia
About Ipsen ADR Rep 1/4 Ord Shs